Millie Cason

Millie Cason is a senior global business leader with extensive experience in Entrepreneurial, Operational, Marketing Insights, Competitive Intelligence, and Analytics across various industries such as biotech, pharma, diagnostics, consumer technology, and consulting.

She has worked on diverse Therapeutic Areas including immunology, oncology, urology, anti-infectives, neurology, and rare diseases. Millie is known for her visionary leadership, collaborative skills, and building exceptional teams.

With a proven track record in building capabilities, teams, and start-up companies, she excels in change management and leading teams effectively during uncertain times.

Millie Cason has developed strategic insights for product launches like Enbrel in dermatology, Xtandi in prostate cancer, and tivozanib in renal cell carcinoma, while also contributing to pre-launch strategies for aducanumab in Alzheimer's and overseeing the product life cycle of Prograf in transplant rejection.

Her educational background includes a leadership program at Northwestern University's Kellogg School Of Management, an MBA in Entrepreneurship from the University Of Colorado Boulder, and a Bachelor's degree in Biology from Loyola University Chicago.

In her professional journey, she has held key positions such as VP Corporate Insights, Commercial Analytics, & Planning at Exact Sciences, Head of Global Customer & Market Insights for MS at Biogen, Director of Intelligence, Marketing Science at Astellas Pharma US, Vice President US Operations at Deallus Consulting, and Senior Manager in Business Analytics Insights at Amgen.